Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Viral Live‐Attenuated Vaccines (LAVs): Past and Future Directions

6 Dec 2024

Abstract excerpt

Viral infections continue to pose a significant threat to the health of both humans and animals. Currently, live attenuated vaccines (LAVs) remain the most efficacious and widely utilized tool for combating viral infections. Conventional LAVs involve the adaptation of virulent viruses to novel hosts, cell cultures, or suboptimal environments, resulting in a reduction in pathogenicity while retaining...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to vaccines and immunoinformatics approaches
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39639853
DOI: 10.1002/advs.202407241

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Viral Live‐Attenuated Vaccines (LAVs): Past and Future DirectionsPMID 39639853Read ↗

Vaccine and adjuvant design for emerging viruses: mutations, deletions, segments and signaling.Semantic proximity Read ↗

Virus-Like Particle Systems for Vaccine Development against Viruses in the Flaviviridae FamilySemantic proximity Read ↗

Virus-like particle-based vaccines for animal viral infectionsSemantic proximity Read ↗

Production and characterization of vaccines based on flaviviruses defective in replicationSemantic proximity Read ↗

Infectious vaccines.Semantic proximity Read ↗

Research progress and challenges to coronavirus vaccine developmentSemantic proximity Read ↗

Viruses, variants and vaccines.Semantic proximity Read ↗

Platforms, advances, and technical challenges in virus-like particles-based vaccinesSemantic proximity Read ↗

Virus-like particles: The new frontier of vaccines for animal viral infectionsSemantic proximity Read ↗

A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modificationsSemantic proximity Read ↗

Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary useSemantic proximity Read ↗

Should the world collaborate imminently to develop neglected live‐attenuated vaccines for COVID‐19?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.